Autopsy report · NCT00691444

Blind Child Melatonin Treatment Study

“Unique provision in the American Recovery and Reinvestment Act prevented approval of second year no-cost-extension in which completion of analyses were planned.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 years 9 months after it had already started.
• Ran for about 13 years 3 months before it stopped.
• 10 participants enrolled.
• Results were posted on the registry 3 years 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Oregon Health and Science University

Sponsor type

University, hospital or other

Conditions

Blindness

Interventions

Melatonin; Melatonin; Melatonin

Participants

10

Sites

1

Countries

United States

Trials that died the same way

• Early Coronary Angiography Versus Delayed Coronary Angiography
  “Funded study period, including a one-year no cost extension, completed.” (61% match in meaning)
• Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress Testing
  “Study was stopped due to funding and time constraints.” (56% match in meaning)
• Moxonidine in Patients Undergoing Vascular Surgery
  “Study was stopped after pre-definied interim analysis because of no effects” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.